Therapeutic peptides for the treatment of systemic lupus erythematosus: a place in therapy

Fei Xiong, Yi-Ling Hu, Hailing Hsu, Debra J Zack, Nessa Hawkins, Hosung Min, Marina Stolina, Kent Miner, Shu-Yin Joanne Ho, Qing Chen, Sanjay D Khare, Frances Lee, Tom Boone, A novel modality of BAFF-specific inhibitor AMG623 peptibody reduces B-cell number and improves outcomes in murine models of autoimmune disease. Clinical and Experimental Rheumatology. ,vol. 30, pp. 197- 201 ,(2012)

Molly Dayan, Raphael Segal, Zev Sthoeger, Ari Waisman, Na’ama Brosh, Ori Elkayam, Eran Eilat, Mati Fridkin, Edna Mozes, Immune response of SLE patients to peptides based on the complementarity determining regions of a pathogenic anti-DNA monoclonal antibody. Journal of Clinical Immunology. ,vol. 20, pp. 187- 194 ,(2000) , 10.1023/A:1006685413157

Rossella Talotta, Angela Berzi, Fabiola Atzeni, Alberto Batticciotto, Mario Clerici, Piercarlo Sarzi-Puttini, Daria Trabattoni, Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response Journal of Clinical Immunology. ,vol. 35, pp. 550- 557 ,(2015) , 10.1007/S10875-015-0182-0

B. Diamond, O. Bloom, Y. Al Abed, C. Kowal, P. T. Huerta, B. T. Volpe, Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus Journal of Internal Medicine. ,vol. 269, pp. 36- 44 ,(2011) , 10.1111/J.1365-2796.2010.02318.X

Lorraine A. DeGiorgio, Konstantin N. Konstantinov, Sunhee C. Lee, John A. Hardin, Bruce T. Volpe, Betty Diamond, A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus Nature Medicine. ,vol. 7, pp. 1189- 1193 ,(2001) , 10.1038/NM1101-1189

Christophe Macri, Fengjuan Wang, Inmaculada Tasset, Nicolas Schall, Nicolas Page, Jean-Paul Briand, Ana Maria Cuervo, Sylviane Muller, Modulation of deregulated chaperone-mediated autophagy by a phosphopeptide Autophagy. ,vol. 11, pp. 472- 486 ,(2015) , 10.1080/15548627.2015.1017179

William Stohl, Joan T. Merrill, R. John Looney, Jill Buyon, Daniel J. Wallace, Michael H. Weisman, Ellen M. Ginzler, Blaire Cooke, Donna Holloway, Arunan Kaliyaperumal, Kameswara Rao Kuchimanchi, Tsui Chern Cheah, Erik Rasmussen, John Ferbas, Shelley S. Belouski, Wayne Tsuji, Debra J. Zack, Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials. Arthritis Research & Therapy. ,vol. 17, pp. 215- 215 ,(2015) , 10.1186/S13075-015-0741-Z

Y. Xia, E. Eryilmaz, E. Der, R. D. Pawar, X. Guo, D. Cowburn, C. Putterman, A peptide mimic blocks the cross‐reaction of anti‐DNA antibodies with glomerular antigens Clinical and Experimental Immunology. ,vol. 183, pp. 369- 379 ,(2016) , 10.1111/CEI.12734

Ying Pan, Stacieann C. Yuhasz, L. Mario Amzel, Anti-idiotypic antibodies: biological function and structural studies. The FASEB Journal. ,vol. 9, pp. 43- 49 ,(1995) , 10.1096/FASEBJ.9.1.7821758

Mary K. Crow, Type I Interferon in the Pathogenesis of Lupus Journal of Immunology. ,vol. 192, pp. 5459- 5468 ,(2014) , 10.4049/JIMMUNOL.1002795